February 24, 2022The LEADS study – or the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) explores the development of early-onset Alzheimer’s disease and…
February 24, 2021This study is investigating whether CT1812, a novel and promising therapeutic candidate can halt or slow the process of Alzheimer’s…
February 24, 2021The Alzheimer’s Disease Neuroimaging Initiative (ADNI), a landmark study that began in 2004, is a public-private research partnership tasked with…
March 24, 2020Approximately fifty percent of people diagnosed with Alzheimer’s disease or other types of dementia will receive hospice care at the…
March 22, 2020Tau protein is an important target in Alzheimer’s disease (AD), and there is now strong evidence that tau in brain…
February 24, 2020The purpose of the Memory Improvement Through Nicotine Dosing (MIND) study is to determine whether daily transdermal nicotine (patch) will…
February 24, 2019The purpose of the SNIFF study is to find out whether a type of insulin, when administered as a nasal…
February 24, 2019The Connect study tested whether an oral, experimental drug, AZD0530 (saracatinib), would slow progression in early stage Alzheimer’s disease (AD).…
Follow us on:
